Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CTSD | P07339 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23234942 | 0.88 | LMNA (0.49) | ALDH1A1TSHRLMNAHPGDMEN1 | |
| SCHEMBL28690767 | 0.87 | LMNA (0.38) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| SCHEMBL888133 | 0.87 | ALDH1A1 (0.53) | ALDH1A1TSHRHPGDMEN1KMT2A | |
| SCHEMBL30605656 | 0.85 | MAOB (0.54) | ALDH1A1TSHRLMNAHPGDMEN1 | |
| SCHEMBL37410 | 0.85 | MAOB (0.54) | ALDH1A1TSHRLMNAHPGDMEN1 | |
| SCHEMBL888134 | 0.85 | ALDH1A1 (0.51) | ALDH1A1TSHRHPGDMEN1KMT2A | |
| SCHEMBL888136 | 0.85 | ALDH1A1 (0.51) | ALDH1A1TSHRHPGDMEN1KMT2A | |
| SCHEMBL5682398 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TSHRLMNAHPGDMEN1 | |
| SCHEMBL7421292 | 0.84 | MAOB (0.52) | ALDH1A1TSHRHPGDMEN1KMT2A | |
| SCHEMBL4314662 | 0.81 | ALDH1A1 (0.54) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220056002-A1 | PHOTOCLEAVABLE LINKER FOR CATCHING AND/OR RELEASING OF CIRCULATING TUMOR CELLS OR EXTRA CELLULAR VESICLES | THE UNIVERSITY OF KANSAS (US) | 2022-02-24 | — | — | US | claimed |
| WO-2020132618-A1 | PHOTOCLEAVABLE LINKER FOR CATCHING AND/OR RELEASING OF CIRCULATING TUMOR CELLS OR EXTRACELLULAR VESICLES | THE UNIVERSITY OF KANSAS (US) | 2020-06-25 | — | — | WO | claimed |
| US-20130095471-A1 | 3'-OH UNBLOCKED NUCLEOTIDES AND NUCLEOSIDES BASE MDIFIED WITH NON-CLEAVABLE, TERMINATING GROUPS AND METHODS FOR THEIR USE IN DNA SEQUENCING | WU WEIDONG (US) | 2013-04-18 | — | — | US | claimed |
| US-20130072388-A1 | PHOTOCLEAVABLE LABELED NUCLEOTIDES AND NUCLEOSIDES AND METHODS FOR THEIR USE IN IN DNA SEQUENCING | AGILENT TECHNOLOGIES, INC. | 2013-03-21 | — | — | US | claimed |
| EP-2125856-A2 | PHOTOCLEAVABLE LABELED NUCLEOTIDES AND NUCLEOSIDES AND LABELED NUCLEOTIDES AND NUCLEOSIDES AND METHODS FOR THEIR USE IN DNA SEQUENCING | Lasergen, Inc. (US) | 2009-12-02 | — | — | EP | claimed |
| US-20090081686-A1 | PHOTOCLEAVABLE LABELED NUCLEOTIDES AND NUCLEOSIDES AND METHODS FOR THEIR USE IN DNA SEQUENCING | AGILENT TECHNOLOGIES, INC. | 2009-03-26 | — | — | US | claimed |
| WO-2008070749-A2 | PHOTOCLEAVABLE LABELED NUCLEOTIDES AND NUCLEOSIDES AND LABELED NUCLEOTIDES AND NUCLEOSIDES AND METHODS FOR THEIR USE IN DNA SEQUENCING | LASERGEN, INC. (US) | 2008-06-12 | — | — | WO | claimed |
| US-20080132692-A1 | Photocleavable labeled nucleotides and nucleosides and methods for their use in DNA sequencing | AGILENT TECHNOLOGIES, INC. | 2008-06-05 | — | — | US | claimed |
| US-20080131952-A1 | Labeled nucleotides and nucleosides and methods for their use in DNA sequencing | AGILENT TECHNOLOGIES, INC. | 2008-06-05 | — | — | US | claimed |
| EP-4419513-B1 | ANTITUMORAL COMPOUNDS | PHARMA MAR SA (ES) | 2025-08-27 | — | — | EP | disclosed |
| US-12384800-B2 | Antitumoral compounds | PHARMA MAR, S.A. (ES) | 2025-08-12 | — | — | US | disclosed |
| US-20250243174-A1 | ANTITUMORAL COMPOUNDS | PHARMA MAR, S.A. (ES) | 2025-07-31 | — | — | US | disclosed |
| US-20250196456-A1 | METHOD FOR THE MANUFACTURING OF AN OPTICAL ELEMENT, OPTICAL ELEMENT THUS OBTAINED | ESSILOR INTERNATIONAL (FR) | 2025-06-19 | — | — | US | disclosed |
| WO-2025077996-A1 | SYNTHETIC PROCESS FOR THE MANUFACTURE OF ECTEINASCIDIN COMPOUNDS | PHARMA MAR, S.A. (ES) | 2025-04-17 | — | — | WO | disclosed |
| US-20080132692-A1 | Photocleavable labeled nucleotides and nucleosides and methods for their use in DNA sequencing | AGILENT TECHNOLOGIES, INC. | 2008-06-05 | — | — | US | disclosed |
| US-20080131952-A1 | Labeled nucleotides and nucleosides and methods for their use in DNA sequencing | AGILENT TECHNOLOGIES, INC. | 2008-06-05 | — | — | US | disclosed |
| WO-2007062664-A2 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2007-06-07 | — | — | WO | disclosed |
| US-20060194016-A1 | Reactive materials for limited play optical devices and methods of making same | FLEXPLAY TECHNOLOGIES, INC. (US) | 2006-08-31 | — | — | US | disclosed |
| US-7026029-B2 | optical recording media such as compact and/or digital video disks comprising multilayers having reduced dyes such as triisopropylsilyloxycarbonylleucomethylene blue, polymers, photostabilizers and binders on substrates | LINDHOLM EDWARD P | 2006-04-11 | — | — | US | disclosed |
| US-20040137188-A1 | Reactive materials for limited play optical devies and methods of making same | LINDHOLM EDWARD P (US) | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132692-A1 | Photocleavable labeled nucleotides and nucleosides and methods for their use in DNA sequencing | UNG, DCLRE1B, NT5C3B | ALDH1A1 3957/4885TSHR 4189/4885LMNA 131/4885 |
| US-12384800-B2 | Antitumoral compounds | TP53, TOP1, MCL1 | ALDH1A1 144/4885TSHR 4670/4885LMNA 1898/4885 |
| US-20220056002-A1 | PHOTOCLEAVABLE LINKER FOR CATCHING AND/OR RELEASING OF CIRCULATING TUMOR CELLS OR EXTRA CELLULAR VESICLES | EXOSC10, ADAM10, HCCS | ALDH1A1 32/4885TSHR 1479/4885LMNA 106/4885 |
| US-20250243174-A1 | ANTITUMORAL COMPOUNDS | MCL1, XPOT, GZMB | ALDH1A1 318/4885TSHR 3614/4885LMNA 1550/4885 |
| US-20130095471-A1 | 3'-OH UNBLOCKED NUCLEOTIDES AND NUCLEOSIDES BASE MDIFIED WITH NON-CLEAVABLE, TERMINATING GROUPS AND METHODS FOR THEIR USE IN DNA SEQUENCING | NT5C3B, UNG, OGG1 | ALDH1A1 1593/4885TSHR 4645/4885LMNA 223/4885 |
| US-20130072388-A1 | PHOTOCLEAVABLE LABELED NUCLEOTIDES AND NUCLEOSIDES AND METHODS FOR THEIR USE IN IN DNA SEQUENCING | UNG, NT5C3B, OGG1 | ALDH1A1 3625/4885TSHR 4099/4885LMNA 129/4885 |
| US-20080131952-A1 | Labeled nucleotides and nucleosides and methods for their use in DNA sequencing | OGG1, NT5C3B, UNG | ALDH1A1 3025/4885TSHR 4076/4885LMNA 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.